Cargando…
Serum Calprotectin as a Promising Inflammatory Biomarker in Psoriatic Arthritis: a 1-Year Longitudinal Study
INTRODUCTION: There are few biomarkers correlated with psoriatic arthritis (PsA). We aimed to explore the clinical value of calprotectin (CLP) in PsA in disease activity and treatment targets. METHODS: Serum CLP was detected by enzyme-linked immunosorbent assay (ELISA) in 71 patients with PsA, 55 pa...
Autores principales: | Li, Borui, Li, Guangtao, Song, Zhibo, Zhang, Zhuoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931953/ https://www.ncbi.nlm.nih.gov/pubmed/36271188 http://dx.doi.org/10.1007/s40744-022-00501-5 |
Ejemplares similares
-
NETosis in Psoriatic Arthritis: Serum MPO–DNA Complex Level Correlates With Its Disease Activity
por: Li, Borui, et al.
Publicado: (2022) -
Clinical Characteristics of Psoriatic Arthritis in Chinese Patients: A Cross-Sectional Study
por: Song, Zhibo, et al.
Publicado: (2021) -
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
por: Jarlborg, Matthias, et al.
Publicado: (2020) -
Discrepancy in Metabolic Syndrome between Psoriatic Arthritis and Rheumatoid Arthritis: a Direct Comparison of Two Cohorts in One Center
por: Li, Borui, et al.
Publicado: (2022) -
Serum Calprotectin Level Is Independently Associated With Carotid Plaque Presence in Patients With Psoriatic Arthritis
por: Cheng, Isaac T., et al.
Publicado: (2022)